Common delivery systems for enhancing in vivo bioavailability and biological efficacy of nutraceuticals

Journal of Functional Foods

Volumn 7, Issue 1, 2014, Pages 112-128

  Ting, Yuwen ^a   Jiang, Yike ^a   Ho, Chi Tang ^a   Huang, Qingrong ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Bioavailability; Delivery systems; Emulsions; Nutraceuticals

Indexed keywords

EID: 84898053516     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2013.12.010     Document Type: Review

References (116)

1. Akhtar F., Rizvi M., Kar S.K. Oral delivery of curcumin bound to chitosan nanoparticles cured Plasmodium yoelii infected mice. Biotechnology Advances 2012, 30:310-320.
2. Almeida A.J., Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Advanced Drug Delivery Reviews 2007, 59:478-490.
3. Artursson P., Lindmark T., Davis S.S., Illum L. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharmaceutical Research 1994, 11:1358-1361.
4. Aungst B.J. Intestinal permeation enhancers. Journal of Pharmaceutical Sciences 2000, 89:429-442.
5. Banga A.K., Chien Y.W. Systemic delivery of therapeutic peptides and proteins. International Journal of Pharmaceutics 1988, 48:15-50.
6. Bell L.N. Stability testing of nutraceuticals and functional foods. Handbook of nutraceuticals and functional foods 2001, 501-516. CRC Press, New York. R.E.C. Wildman (Ed.).
7. Belluti F., Fontana G., Bo L.D., Carenini N., Giommarelli C., Zunino F. Design, synthesis and anticancer activities of stilbene-coumarin hybrid compounds: Identification of novel proapoptotic agents. Bioorganic & Medicinal Chemistry 2010, 18:3543-3550.
8. Bernal J., Mendiola J.A., Ibanez E., Cifuentes A. Advanced analysis of nutraceuticals. Journal of Pharmaceutical and Biomedical Analysis 2011, 55:758-774.
9. Bernkop-Schnürch A. Chitosan and its derivatives: Potential excipients for peroral peptide delivery systems. International Journal of Pharmaceutics 2000, 194:1-13.
10. Chakraborty S., Shukla D., Mishra B., Singh S. Lipid, an emerging platform for oral delivery of drugs with poor bioavailability. European Journal of Pharmaceutics and Biopharmaceutics 2009, 73:1-15.
11. Chauhan B., Kumar G., Kalam N., Ansari S. Current concepts and prospects of herbal nutraceutical: A review. Journal of Advanced Pharmaceutical Technology & Research 2013, 4:4.
12. Chen J. Food oral processing - A review. Food Hydrocolloids 2009, 23:1-25.
13. Chen Z.P., Sun J., Chen H.X., Xiao Y.Y., Liu D., Chen J., Cai H., Cai B.C. Comparative pharmacokinetics and bioavailability studies of quercetin, kaempferol and isorhamnetin after oral administration of Ginkgo biloba extracts, Ginkgo biloba extract phospholipid complexes and Ginkgo biloba extract solid dispersions in rats. Fitoterapia 2010, 81:1045-1052.
14. Chiou Y.-S., Ma N.J.-L., Sang S., Ho C.-T., Wang Y.-J., Pan M.-H. Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently suppresses dextran sulfate sodium-induced colitis and colon tumorigenesis in mice. Journal of Agricultural and Food Chemistry 2012, 60:3441-3451.
15. Chiou Y.-S., Sang S., Cheng K.-H., Ho C.-T., Wang Y.-J., Pan M.-H. Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently prevents skin carcinogenesis by suppressing the PKD1-dependent signaling pathway in CD34+ skin stem cells and skin tumors. Carcinogenesis 2013, 34:1315-1322.
16. Chopraa S., Kohlia K., Aroraa S., Khara R.K. In-situ nano-emulsification technique for enhancing oral bioavailability of curcumin and thereby evaluating its anticancer efficacy on human lung adeno-carcinoma epithelial cell line. Journal of Pharmacy Research 2011, 4:4087-4093.
17. Date A.A., Nagarsenker M.S., Patere S., Dhawan V., Gude R., Hassan P., Aswal V., Steiniger F., Thamm J., Fahr A. Lecithin-based novel cationic nanocarriers (leciplex) II: Improving therapeutic efficacy of quercetin on oral administration. Molecular Pharmaceutics 2011, 8:716-726.
18. Deshpande A., Rhodes C., Shah N., Malick A. Controlled-release drug delivery systems for prolonged gastric residence: An overview. Drug Development and Industrial Pharmacy 1996, 22:531-539.
19. Dube A., Ng K., Nicolazzo J.A., Larson I. Effective use of reducing agents and nanoparticle encapsulation in stabilizing catechins in alkaline solution. Food Chemistry 2010, 122:662-667.
20. Dube A., Nicolazzo J.A., Larson I. Chitosan nanoparticles enhance the plasma exposure of (-)-epigallocatechin gallate in mice through an enhancement in intestinal stability. European Journal of Pharmaceutical Sciences 2011, 44:422-426.
21. Ehrman T.M., Barlow D.J., Hylands P.J. Phytochemical databases of Chinese herbal constituents and bioactive plant compounds with known target specificities. Journal of Chemical Information and Modeling 2007, 47:254-263.
22. El-Samaligy M.S., Afifi N.N., Mahmoud E.A. Evaluation of hybrid liposomes-encapsulated silymarin regarding physical stability and in vivo performance. International Journal of Pharmaceutics 2006, 319:121-129.
23. Filburn C., Kettenacker R., Griffin D. Bioavailability of a silybin, a phosphatidylcholine complex in dogs. Journal of Veterinary Pharmacology and Therapeutics 2007, 30:132-138.
24. Fricker G., Kromp T., Wendel A., Blume A., Zirkel J., Rebmann H., Setzer C., Quinkert R.-O., Martin F., Müller-Goymann C. Phospholipids and lipid-based formulations in oral drug delivery. Pharmaceutical Research 2010, 27:1469-1486.
25. Ghosh D., Choudhury S.T., Ghosh S., Mandal A.K., Sarkar S., Ghosh A., Saha K.D., Das N. Nanocapsulated curcumin: Oral chemopreventive formulation against diethylnitrosamine induced hepatocellular carcinoma in rat. Chemico-Biological Interactions 2012, 195:206-214.
26. Ghosh A., Mandal A.K., Sarkar S., Panda S., Das N. Nanoencapsulation of quercetin enhances its dietary efficacy in combating arsenic-induced oxidative damage in liver and brain of rats. Life Sciences 2009, 84:75-80.
27. Guazelli C.F., Fattori V., Colombo B.B., Georgetti S.R., Vicentini F.T., Casagrande R., Baracat M.M., Verri W.A. Quercetin-loaded microcapsules ameliorate experimental colitis in mice by anti-inflammatory and antioxidant mechanisms. Journal of Natural Products 2013, 76:200-208.
28. Guengerich F.P. Cytochrome p450 and chemical toxicology. Chemical Research in Toxicology 2007, 21:70-83.
29. Gui S.Y., Wu L., Peng D.Y., Liu Q.Y., Yin B.P., Shen J.Z. Preparation and evaluation of a microemulsion for oral delivery of berberine. Die Pharmazie - An International Journal of Pharmaceutical Sciences 2008, 63:516-519.
30. Gupta S., Moulik S.P. Biocompatible microemulsions and their prospective uses in drug delivery. Journal of Pharmaceutical Sciences 2008, 97:22-45.
31. Hatanaka J., Chikamori H., Sato H., Uchida S., Debari K., Onoue S., Yamada S. Physicochemical and pharmacological characterization of α-tocopherol-loaded nano-emulsion system. International Journal of Pharmaceutics 2010, 396:188-193.
32. Hebert M. Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery. Advanced Drug Delivery Reviews 1997, 27:201-214.
33. Holst B., Williamson G. Nutrients and phytochemicals: From bioavailability to bioefficacy beyond antioxidants. Current Opinion in Biotechnology 2008, 19:73-82.
34. Hu B., Ting Y., Yang X., Tang W., Zeng X., Huang Q. Nanochemoprevention by encapsulation of (-)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability. Chemical Communications 2012, 48:2421-2423.
35. Hu B., Ting Y., Zeng X., Huang Q. Cellular uptake and cytotoxicity of chitosan-caseinophosphopeptides nanocomplexes loaded with epigallocatechin gallate. Carbohydrate Polymers 2012, 89:362-370.
36. Huang Y.B., Tsai M.J., Wu P.C., Tsai Y.H., Wu Y.H., Fang J.Y. Elastic liposomes as carriers for oral delivery and the brain distribution of (+)-catechin. Journal of Drug Targeting 2011, 19:709-718.
37. Huang Q.R., Yu H.L., Ru Q.M. Bioavailability and delivery of nutraceuticals using nanotechnology. Journal of Food Science 2010, 75:50-57.
38. Humberstone A.J., Charman W.N. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Advanced Drug Delivery Reviews 1997, 25:103-128.
39. Husch J., Gerbeth K., Fricker G., Setzer C., Zirkel J., Rebmann H., Schubert-Zsilavecz M., Abdel-Tawab M. Effect of phospholipid-based formulations of Boswellia serrata extract on the solubility, permeability, and absorption of the individual boswellic acid constituents present. Journal of Natural Products 2012, 75:1675-1682.
40. Korhonen H., Pihlanto A. Bioactive peptides: Production and functionality. International Dairy Journal 2006, 16:945-960.
41. Kumar K.V., Sivakumar T., Mani T.T. Colon targeting drug delivery system: A review on recent approaches. International Journal of Pharmaceutical and Biomedical Sciences 2011, 2:11-19.
42. Lambert J.D., Sang S., Hong J., Kwon S.-J., Lee M.-J., Ho C.-T., Yang C.S. Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate. Drug Metabolism and Disposition 2006, 34:2111-2116.
43. Langer R. Invited review polymeric delivery systems for controlled drug release. Chemical Engineering Communications 1980, 6:1-48.
44. Larrosa M., TomeÃÅ-Carneiro J., YaÃÅnÃÉez-GascoÃÅn M.J., AlcaÃÅntara D., Selma M.V., BeltraÃÅn D., GarciÃÅa-Conesa M.T., UrbaÃÅn C., Lucas R., TomaÃÅs-BarberaÃÅn F. Preventive oral treatment with resveratrol pro-prodrugs drastically reduce colon inflammation in rodents. Journal of Medicinal Chemistry 2010, 53:7365-7376.
45. Lau Y.T., Chen N., Ko K.M., Ng K.M. Product design: A nanomized nutraceutical with enhanced bioactivity and bioavailability. Industrial & Engineering Chemistry Research 2012, 51:7320-7326.
46. Li H., Zhao X., Ma Y., Zhai G., Li L., Lou H. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. Journal of Controlled Release 2009, 133:238-244.
47. Li Y., Zheng J., Xiao H., McClements D.J. Nanoemulsion-based delivery systems for poorly water-soluble bioactive compounds: Influence of formulation parameters on polymethoxyflavone crystallization. Food Hydrocolloids 2011, 1.
48. Liang L., Liu X., Wang Q., Cheng S., Zhang S., Zhang M. Pharmacokinetics, tissue distribution and excretion study of resveratrol and its prodrug 3,5,4'-tri-O-acetylresveratrol in rats. Phytomedicine 2013, 20:558-563.
49. Lin J.H., Chiba M., Baillie T.A. Is the role of the small intestine in first-pass metabolism overemphasized?. Pharmacological Reviews 1999, 51:135-158.
50. Lin W., Hong J.-L., Shen G., Wu R.T., Wang Y., Huang M.-T., Newmark H.L., Huang Q., Khor T.O., Heimbach T., Kong A.-N. Pharmacokinetics of dietary cancer chemopreventive compound dibenzoylmethane in rats and the impact of nanoemulsion and genetic knockout of Nrf2 on its disposition. Biopharmaceutics & Drug Disposition 2011, 32:65-75.
51. Lin Y.-H., Sonaje K., Lin K.M., Juang J.-H., Mi F.-L., Yang H.-W., Sung H.-W. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs. Journal of Controlled Release 2008, 132:141-149.
52. Lindahl A., Ungell A.-L., Knutson L., Lennernäs H. Characterization of fluids from the stomach and proximal jejunum in men and women. Pharmaceutical Research 1997, 14:497-502.
53. Liu W., Tian R., Hu W., Jia Y., Jiang H., Zhang J., Zhang L. Preparation and evaluation of self-microemulsifying drug delivery system of baicalein. Fitoterapia 2012, 83:1532-1539.
54. Lun Su Y., Leung L.K., Huang Y., Chen Z.-Y. Stability of tea theaflavins and catechins. Food Chemistry 2003, 83:189-195.
55. Maiti K., Mukherjee K., Gantait A., Nazeer Ahamed H., Saha B.P., Kumar Mukherjee P. Enhanced therapeutic benefit of quercetinphospholipid complex in carbon tetrachloride-induced acute liver injury in rats: A comparative study. Iranian Journal of Pharmacology & Therapeutics (IJPT) 2005, 4:84-90.
56. Maiti K., Mukherjee K., Gantait A., Saha B.P., Mukherjee P.K. Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. International Journal of Pharmaceutics 2007, 330:155-163.
57. Manach C., Williamson G., Morand C., Scalbert A., Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. The American Journal of Clinical Nutrition 2005, 81:230S-242S.
58. Martinez M.N., Amidon G.L. A mechanistic approach to understanding the factors affecting drug absorption: A review of fundamentals. The Journal of Clinical Pharmacology 2002, 42:620-643.
59. Mattila-Sandholm T., Myllärinen P., Crittenden R., Mogensen G., Fonden R., Saarela M. Technological challenges for future probiotic foods. International Dairy Journal 2002, 12:173-182.
60. McClements D.J. Emulsion design to improve the delivery of functional lipophilic components. Annual Review of Food Science and Technology 2010, 1(1):241-269.
61. McClements D.J., Decker E.A., Park Y., Weiss J. Designing food structure to control stability, digestion, release and absorption of lipophilic food components. Food Biophysics 2008, 3:219-228.
62. McClements D.J., Li Y. Review of in vitro digestion models for rapid screening of emulsion-based systems. Food & Function 2010, 1:32-59.
63. McClements D.J., Li Y. Structured emulsion-based delivery systems: Controlling the digestion and release of lipophilic food components. Advances in Colloid and Interface Science 2010, 159:213-228.
64. McClements J., Weiss J. Lipid emulsions. Bailey's industrial oil and fat products 2005, 457-502. John Wiley and Sons Inc. 6th ed. F. Shahidi (Ed.).
65. McMurchie E.J. Dietary lipids and the regulation of membrane fluidity and function. Physiological Regulation of Membrane Fluidity 1988, 3:189-237.
66. Mehta R.C., Jeyanthi R., Thanoo B., Burton K.W., DeLuca P.P. Biodegradable microspheres as depot system for parenteral delivery of peptide drugs. Journal of Controlled Release 1994, 29:375-384.
67. Mei Z., Li X., Wu Q., Hu S., Yang X. The research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticle. Pharmacological Research 2005, 51:345-351.
68. Mulholland P., Ferry D., Anderson D., Hussain S., Young A., Cook J., Hodgkin E., Seymour L., Kerr D. Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin. Annals of Oncology 2001, 12:245-248.
69. Müller R.H., Mäder K., Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - A review of the state of the art. European Journal of Pharmaceutics and Biopharmaceutics 2000, 50:161-177.
70. Ninomiya M., Tanaka K., Tsuchida Y., Muto Y., Koketsu M., Watanabe K. Increased bioavailability of tricin-amino acid derivatives via a prodrug approach. Journal of Medicinal Chemistry 2011, 54:1529-1536.
71. Nordgaard I., Mortensen P.B. Digestive processes in the human colon. Nutrition (Burbank, Los Angeles County, Calif.) 1995, 11:37.
72. Pathan R.A., Bhandari U., Javed S., Nag T.C. Anti-apoptotic potential of gymnemic acid phospholipid complex pretreatment in Wistar rats with experimental cardiomyopathy. Indian Journal of Experimental Biology 2012, 50:117-127.
73. Pelkonen O., Boobis A.R., Gundert-Remy U. In vitro prediction of gastrointestinal absorption and bioavailability: An experts' meeting report. European Journal of Clinical Pharmacology 2001, 57:621-629.
74. Porter C.J.H., Trevaskis N.L., Charman W.N. Lipids and lipid-based formulations: Optimizing the oral delivery of lipophilic drugs. Nature Reviews. Drug Discovery 2007, 6:231-248.
75. Pridgen E.M., Langer R., Farokhzad O.C. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy. Nanomedicine 2007, 2:669-680.
76. Rajwar S., Khatri P., Patel R., Dwivedi S., Dwivedi A. An overview on potent herbal anticancer drugs. International Journal of Research in Pharmacy and Chemistry 2011, 1:202-210.
77. Ranadheera R., Baines S., Adams M. Importance of food in probiotic efficacy. Food Research International 2010, 43:1-7.
78. Rouge N., Buri P., Doelker E. Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. International Journal of Pharmaceutics 1996, 136:117-139.
79. Samad A., Sultana Y., Aqil M. Liposomal drug delivery systems: An update review. Current Drug Delivery 2007, 4:297-305.
80. Sastry S.V., Nyshadham J.R., Fix J.A. Recent technological advances in oral drug delivery, a review. Pharmaceutical Science & Technology Today 2000, 3:138-145.
81. Schwarz C., Mehnert W., Lucks J.S., Müller R.H. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. Journal of Controlled Release 1994, 30:83-96.
82. Shackleford D.M., Porter C.J., Charman W.N. Lymphatic absorption of orally administered prodrugs. Prodrugs 2007, 653-682. Springer.
83. Shan B., Cai Y.Z., Sun M., Corke H. Antioxidant capacity of 26 spice extracts and characterization of their phenolic constituents. Journal of Agricultural and Food Chemistry 2005, 53:7749-7759.
84. Shao B., Tang J., Ji H., Liu H., Liu Y., Zhu D., Wu L. Enhanced oral bioavailability of Wurenchun (Fructus Schisandrae Chinensis Extracts) by self-emulsifying drug delivery systems. Drug Development and Industrial Pharmacy 2010, 36:1356-1363.
85. Shegokar R., Muller R.H. Nanocrystals: Industrially feasible multifunctional formulation technology for poorly soluble actives. International Journal of Pharmaceutics 2010, 399:129-139.
86. Singla A.K., Chawla M., Singh A. Potential applications of carbomer in oral mucoadhesive controlled drug delivery system: A review. Drug Development and Industrial Pharmacy 2000, 26:913-924.
87. Sun M., Gao Y., Pei Y., Guo C., Li H., Cao F., Yu A., Zhai G. Development of nanosuspension formulation for oral delivery of quercetin. Journal of Biomedical Nanotechnology 2010, 6:325-332.
88. Sun J., Wang F., Sui Y., She Z., Zhai W., Wang C., Deng Y. Effect of particle size on solubility, dissolution rate, and oral bioavailability: evaluation using coenzyme Q10 as naked nanocrystals. International Journal of Nanomedicine 2012, 7:5733.
89. Takahashi M., Uechi S., Takara K., Asikin Y., Wada K. Evaluation of an oral carrier system in rats: Bioavailability and antioxidant properties of liposome-encapsulated curcumin. Journal of Agricultural and Food Chemistry 2009, 57:9141-9146.
90. Tan Q., Liu S., Chen X., Wu M., Wang H., Yin H., He D., Xiong H., Zhang J. Design and evaluation of a novel evodiamine-phospholipid complex for improved oral bioavailability. AAPS PharmSciTech 2012, 13:534-547.
91. Tang J.-L., Sun J., He Z.-G. Self-emulsifying drug delivery systems: Strategy for improving oral delivery of poorly soluble drugs. Current Drug Therapy 2007, 2:85-93.
92. Thanou M., Verhoef J.C., Junginger H.E. Oral drug absorption enhancement by chitosan and its derivatives. Advanced Drug Delivery Reviews 2001, 52:117-126.
93. Ting Y., Li C.C., Pan M.-H., Ho C.-T., Huang Q. Effect of labile methyl donor on the transformation of 5-demethyl tangeretin and related implication on bioactivity. Journal of Agricultural and Food Chemistry 2013, 61:8090-8097.
94. Ting Y., Xia Q., Li S., Ho C.-T., Huang Q. Design of high-loading and high-stability viscoelastic emulsions for polymethoxyflavones. Food Research International 2013, 54:633-640.
95. Torchilin V.P. Structure and design of polymeric surfactant-based drug delivery systems. Journal of Controlled Release 2001, 73:137.
96. Torchilin V.P., Lukyanov A.N. Peptide and protein drug delivery to and into tumors: Challenges and solutions. Drug Discovery Today 2003, 8:259-266.
97. Trevaskis N.L., Charman W.N., Porter C.J.H. Lipid-based delivery systems and intestinal lymphatic drug transport: A mechanistic update. Advanced Drug Delivery Reviews 2008, 60:702-716.
98. van Duynhoven J., Vaughan E.E., Jacobs D.M., Kemperman R.A., van Velzen E.J., Gross G., Roger L.C., Possemiers S., Smilde A.K., Doré J.l. Metabolic fate of polyphenols in the human superorganism. Proceedings of the National Academy of Sciences 2011, 108:4531-4538.
99. Vingerhoeds M.H., Blijdenstein T.B., Zoet F.D., van Aken G.A. Emulsion flocculation induced by saliva and mucin. Food Hydrocolloids 2005, 19:915-922.
100. Wang, X. Y., Jiang, Y., & Huang, Q. R. (2008). Encapsulation and controlled release technologies in food systems. In J.M. Lakkis (Ed.), pp. 135. Wiley-Blackwell.
101. Wang X., Jiang Y., Wang Y.-W., Huang M.-T., Ho C.-T., Huang Q. Enhancing anti-inflammation activity of curcumin through O/W nanoemulsions. Food Chemistry 2008, 108:419-424.
102. Wang Y., Ma Y., Zheng Y., Song J., Yang X., Bi C., Zhang D., Zhang Q. In vitro and in vivo anticancer activity of a novel puerarin nanosuspension against colon cancer, with high efficacy and low toxicity. International Journal of Pharmaceutics 2013, 441:728-735.
103. Wang X., Wang Y.-W., Huang Q. Enhancing stability and oral bioavailability of polyphenols using nanoemulsions. ACS symposium series 2009, Vol. 1007:198-212. ACS Publications.
104. Weaver L., Austin S., Cole T. Small intestinal length: A factor essential for gut adaptation. Gut 1991, 32:1321-1323.
105. Wilkinson G.R. Drug metabolism and variability among patients in drug response. New England Journal of Medicine 2005, 352:2211-2221.
106. Xiao Y.Y., Song Y.M., Chen Z.P., Ping Q.N. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats. International Journal of Pharmaceutics 2006, 307:77-82.
107. Xiao Y.Y., Song Y.M., Chen Z.P., Ping Q.N. Preparation of silymarin proliposome: A new way to increase oral bioavailability of silymarin in beagle dogs. International Journal of Pharmaceutics 2006, 319:162-168.
108. Yang X., Tian H., Ho C.-T., Huang Q. Stability of citral in emulsions coated with cationic biopolymer layers. Journal of Agricultural and Food Chemistry 2011, 60:402-409.
109. Yang S., Zhu J., Lu Y., Liang B., Yang C. Body distribution of camptothecin solid lipid nanoparticles after oral administration. Pharmaceutical Research 1999, 16:751-757.
110. Yen F.-L., Wu T.-H., Lin L.-T., Cham T.-M., Lin C.-C. Nanoparticles formulation of Cuscuta chinensis prevents acetaminophen-induced hepatotoxicity in rats. Food and Chemical Toxicology 2008, 46:1771-1777.
111. Yen F.-L., Wu T.-H., Lin L.-T., Cham T.-M., Lin C.-C. Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl4-induced acute liver failure. Pharmaceutical Research 2009, 26:893-902.
112. You J., Cui F.-D., Li Q.-P., Han X., Yu Y.-W., Yang M.-S. A novel formulation design about water-insoluble oily drug: Preparation of zedoary turmeric oil microspheres with self-emulsifying ability and evaluation in rabbits. International Journal of Pharmaceutics 2005, 288:315-323.
113. Yu H., Huang Q. Improving the oral bioavailability of curcumin using novel organogel-based nanoemulsions. Journal of Agricultural and Food Chemistry 2012, 60:5373-5379.
114. Yu A., Wang H., Wang J., Cao F., Gao Y., Cui J., Zhai G. Formulation optimization and bioavailability after oral and nasal administration in rabbits of puerarin-loaded microemulsion. Journal of Pharmaceutical Sciences 2011, 100:933-941.
115. Zhang P., Liu Y., Feng N., Xu J. Preparation and evaluation of self-microemulsifying drug delivery system of oridonin. International Journal of Pharmaceutics 2008, 355:269-276.
116. Zhu Q.Y., Zhang A., Tsang D., Huang Y., Chen Z.-Y. Stability of green tea catechins. Journal of Agricultural and Food Chemistry 1997, 45:4624-4628.